Side by side
Two providers on the same checks, with their prices and who each fits.
Compound against compound
BPC-157 vs TB-500: what is actually known about each
They are sold side by side for injuries and recovery. One has three small uncontrolled human studies; the other has none. Here is how they differ, and where FDA's July 2026 review left them.
CJC-1295 vs sermorelin: the same idea, a different standing with FDA
CJC-1295 was built to fix sermorelin's main limit, its short life in the blood. It never made it to approval. Sermorelin did, then left the market, and reaches patients today through compounding.
CJC-1295 vs tesamorelin: two GHRH copies, one approved drug
Both were developed as longer-acting versions of the same brain hormone, and both were tested in people with HIV. One became Egrifta. The other's patient trial was stopped and never published.
MOTS-c vs NAD+: two mitochondrial pitches, two very different records
Both are sold as ways to recharge your mitochondria. One is a peptide never given to people in a published drug study. The other is a coenzyme every cell already makes, compounded by pharmacies with no outcome trials in healthy adults.
NMN vs NAD+: how a supplement and a compounded shot compare
People ask whether NMN and NAD+ are the same thing, and which one to take. They are related but not the same, they reach you through different channels, and their evidence is different in kind.
Sermorelin vs HGH: the hormone itself, or a signal to make more
One is growth hormone, made by recombinant DNA and approved for specific diagnoses. The other asks your pituitary to release its own. The law treats them very differently, and so do the trials.
Sermorelin vs ipamorelin: one is compounded, one has no pharmacy route
Both raise growth hormone, but through different receptors, with different trial records and a very different standing with FDA. Here is the side-by-side, with the dates.
Tesamorelin vs ipamorelin: an approved brand and a peptide that never was
One has two phase 3 trials and an FDA label. The other has one failed phase 2 trial and a unanimous vote against it. Neither has a pharmacy route, and that changes what "better" can mean.
Tesamorelin vs sermorelin: two GHRH drugs with very different records
Both peptides tell the pituitary to release growth hormone, and online they are often pitched as rival anti-aging options. Their regulatory status, their trials and the way patients get them have almost nothing in common.
Compare sellers
Build a comparison
Pick two providers
3 written comparisons so far.
3 of 3
- AgelessRx vs Hone HealthCompare two clinician-led longevity programs, with special attention to membership charges and pharmacy transparency.
- Strut Health vs Nu Image MedicalLook closely at consultation inclusions, pharmacy disclosure and refill commitments across these two sermorelin programs.
- Eden vs DirectMedsA focused semaglutide comparison covering included costs, state availability and what the wider product catalog tells you.